Insider Transactions in Q4 2023 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 22
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
314
-0.46%
|
$5,024
$16.79 P/Share
|
Dec 17
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
228
+0.18%
|
-
|
Dec 17
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
254
+0.38%
|
-
|
Dec 17
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
705
+0.25%
|
-
|
Dec 17
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
211
+0.35%
|
-
|
Dec 03
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
258
+0.2%
|
-
|
Dec 03
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
796
+0.29%
|
-
|
Dec 03
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
229
+0.38%
|
-
|
Dec 03
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
287
+0.42%
|
-
|
Dec 01
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
303
-0.51%
|
$3,636
$12.37 P/Share
|
Dec 01
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
591
-0.21%
|
$7,092
$12.37 P/Share
|
Dec 01
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
394
-0.91%
|
$4,728
$12.37 P/Share
|
Dec 01
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
466
-0.37%
|
$5,592
$12.37 P/Share
|
Dec 01
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
666
-0.98%
|
$7,992
$12.37 P/Share
|
Dec 01
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
394
-0.33%
|
$4,728
$12.37 P/Share
|
Nov 19
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
234
+0.39%
|
-
|
Nov 19
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
826
+0.3%
|
-
|
Nov 19
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
267
+0.21%
|
-
|
Nov 19
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.44%
|
-
|
Nov 13
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
97
-0.14%
|
$970
$10.66 P/Share
|
Nov 13
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
132
-0.05%
|
$1,320
$10.77 P/Share
|
Nov 13
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
111
-0.19%
|
$1,110
$10.66 P/Share
|
Nov 13
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
98
-0.08%
|
$980
$10.77 P/Share
|
Nov 13
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
76
-0.17%
|
$760
$10.77 P/Share
|
Nov 13
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
114
-0.09%
|
$1,140
$10.77 P/Share
|
Nov 05
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
924
+0.33%
|
-
|
Nov 05
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
333
+0.49%
|
-
|
Nov 05
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
262
+0.44%
|
-
|
Nov 05
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
299
+0.24%
|
-
|
Nov 01
2023
|
Timothy L. Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
495
+2.59%
|
-
|
Nov 01
2023
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
598
+1.99%
|
-
|
Nov 01
2023
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
495
+1.54%
|
-
|
Nov 01
2023
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
577
+1.9%
|
-
|
Nov 01
2023
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
608
+1.83%
|
-
|
Oct 30
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
72,603
-17.3%
|
$653,427
$9.13 P/Share
|
Oct 22
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
373
+0.55%
|
-
|
Oct 22
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,034
+0.37%
|
-
|
Oct 22
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
771
+0.18%
|
-
|
Oct 22
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
291
+0.49%
|
-
|
Oct 22
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
335
+0.27%
|
-
|
Oct 19
2023
|
Garrie Richardson Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,320
+25.64%
|
-
|
Oct 19
2023
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
394,856
+47.15%
|
-
|
Oct 19
2023
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
927,165
+9.78%
|
$10,198,815
$11.19 P/Share
|
Oct 08
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
281
+0.42%
|
-
|
Oct 08
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
282
+0.07%
|
-
|
Oct 08
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
252
+0.2%
|
-
|
Oct 08
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
219
+0.37%
|
-
|
Oct 08
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
779
+0.28%
|
-
|
Oct 01
2023
|
Timothy L. Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
362
+1.96%
|
-
|
Oct 01
2023
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
362
+0.79%
|
-
|